- Home
- JFBR vs CERO Comparison
JFBR vs CERO Comparison
Compare JFBR & CERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JFBR
- CERO
- Stock Information
- Founded
- JFBR 2017
- CERO 2017
- Country
- JFBR Israel
- CERO United States
- Employees
- JFBR N/A
- CERO N/A
- Industry
- JFBR Other Specialty Stores
- CERO
- Sector
- JFBR Consumer Discretionary
- CERO
- Exchange
- JFBR Nasdaq
- CERO Nasdaq
- Market Cap
- JFBR 3.6M
- CERO 3.1M
- IPO Year
- JFBR 2022
- CERO N/A
- Fundamental
- Price
- JFBR $1.08
- CERO $0.73
- Analyst Decision
- JFBR
- CERO
- Analyst Count
- JFBR 0
- CERO 0
- Target Price
- JFBR N/A
- CERO N/A
- AVG Volume (30 Days)
- JFBR 732.7K
- CERO 1.0M
- Earning Date
- JFBR 04-15-2025
- CERO 05-16-2025
- Dividend Yield
- JFBR N/A
- CERO N/A
- EPS Growth
- JFBR N/A
- CERO N/A
- EPS
- JFBR N/A
- CERO N/A
- Revenue
- JFBR $13,688,000.00
- CERO N/A
- Revenue This Year
- JFBR N/A
- CERO N/A
- Revenue Next Year
- JFBR N/A
- CERO N/A
- P/E Ratio
- JFBR N/A
- CERO N/A
- Revenue Growth
- JFBR 66.98
- CERO N/A
- 52 Week Low
- JFBR $0.17
- CERO $0.65
- 52 Week High
- JFBR $3.96
- CERO $223.00
- Technical
- Relative Strength Index (RSI)
- JFBR 31.63
- CERO 26.02
- Support Level
- JFBR $1.00
- CERO $0.65
- Resistance Level
- JFBR $1.34
- CERO $0.80
- Average True Range (ATR)
- JFBR 0.11
- CERO 0.10
- MACD
- JFBR 0.00
- CERO 0.04
- Stochastic Oscillator
- JFBR 20.33
- CERO 20.79
About JFBR Jeffs' Brands Ltd
Jeffs Brands Ltd is an e-commerce CPG company, operating on Amazon. The company serves as the holding company of other e-commerce companies, Smart Repair Pro, Purex, and Top Rank, that operate online stores for the sale of various consumer products on Amazon online marketplace, utilizing the FBA model. The company has five wholly-owned subsidiaries: Smart Repair Pro, Purex, Top Rank , Fort and Jeffs' Brands Holdings. The company also utilizes internal methodologies to analyze sales data and patterns on Amazon in order to identify existing stores, niches and products that have the potential for development and growth, and for maximizing sales of existing proprietary products.
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.